Table 3 Monocyte human leukocyte antigen-DR expression in peripheral blood mononuclear cells of survivors, nonsurvivors and controls on days 1 and 7
Patient characteristics | Survivors (n= 23) | Nonsurvivors (n= 11) | All patients (n= 34) | Controls (n = 30) |
|---|---|---|---|---|
Day 1 | ||||
Monocytes (%) | 11.3 (0.3 to 39.8) | 9.2 (2.7 to 40.5) | 11.1 (0.3 to 40.5) | 3.6† (1.3 to 9.5) |
HLA-DR measurements of positive monocytes (%) | 37.8 (1.7 to 66.8) | 41.9 (22.3 to 80.7) | 41.0 (1.7 to 80.7) | 91.7† (57.3 to 98.4) |
HLA-DR measurements (MFI) | 0.9 (0.6 to 2.9) | 0.8 (0.7 to 1.7) | 0.9 (0.6 to 2.9) | 1.8† (1.4 to 2.6) |
Day 7 | (n = 23) | (n = 6) | (n = 29) | |
Monocytes (%) | 9.2 (1.1 to 31.7) | 15.6 (3.2 to 25.7) | 10.0 (1.1 to 31.7) | |
HLA-DR measurement of positive monocytes (%) | 45.8 (11.4 to 74.9) | 33.4 (18.9 to 71.9) | 40.6 (11.4 to 74.9) | |
HLA-DR measurements (MFI) | 1.2*(0.7 to 1.7) | 0.9 (0.7 to 1.2) | 1.1 (0.7 to 1.7) |